On the public citation graph

Peptide-based materials for cancer immunotherapy

0 signed · 271 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/adfm.201501283openalex-snapshot
Dual Targeted Immunotherapy via In Vivo Delivery of Biohybrid RNAi‐Peptide Nanoparticles to Tumor‐Associated Macrophages and Cancer Cells
inferredcites →https://doi.org/10.1002/adma.201200209openalex-snapshot
Self‐Assembled Peptide Amphiphile Micelles Containing a Cytotoxic T‐Cell Epitope Promote a Protective Immune Response In Vivo
inferredcites →https://doi.org/10.1002/adma.201502598openalex-snapshot
In Situ Formation of Nanofibers from Purpurin18‐Peptide Conjugates and the Assembly Induced Retention Effect in Tumor Sites
inferredcites →https://doi.org/10.1002/anie.201506225openalex-snapshot
Blocking of the PD‐1/PD‐L1 Interaction by a D ‐Peptide Antagonist for Cancer Immunotherapy
inferredcites →https://doi.org/10.1002/chin.201450232openalex-snapshot
ChemInform Abstract: “Click” Reactions: A Versatile Toolbox for the Synthesis of Peptide‐Conjugates
inferredcites →https://doi.org/10.1002/jlb.56.6.672openalex-snapshot
Neutrophils, host defense, and inflammation: a double-edged sword
inferredcites →https://doi.org/10.1002/pep2.24058openalex-snapshot
Unnatural amino acids improve affinity and modulate immunogenicity: Developing peptides to treat MHC type II autoimmune disorders
inferredcites →https://doi.org/10.1007/s00262-012-1366-6openalex-snapshot
Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapy
inferredcites →https://doi.org/10.1007/s00262-018-02294-5openalex-snapshot
The route of administration dictates the immunogenicity of peptide-based cancer vaccines in mice
inferredcites →https://doi.org/10.1007/s10549-009-0666-9openalex-snapshot
A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study
inferredcites →https://doi.org/10.1007/s10549-013-2410-8openalex-snapshot
Vaccination for the prevention and treatment of breast cancer with special focus on Her-2/neu peptide vaccines
inferredcites →https://doi.org/10.1016/b978-0-12-800147-9.00005-4openalex-snapshot
How to Trigger a Killer
inferredcites →https://doi.org/10.1016/j.addr.2004.10.005openalex-snapshot
Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer
inferredcites →https://doi.org/10.1016/j.addr.2010.05.003openalex-snapshot
Cell penetrating elastin-like polypeptides for therapeutic peptide delivery
inferredcites →https://doi.org/10.1016/j.addr.2015.12.007openalex-snapshot
Elastin-like polypeptides in drug delivery
inferredcites →https://doi.org/10.1016/j.addr.2016.06.002openalex-snapshot
Peptide-based strategies for enhanced cell uptake, transcellular transport, and circulation: Mechanisms and challenges
inferredcites →https://doi.org/10.1016/j.addr.2016.06.018openalex-snapshot
Polylactic acid (PLA) controlled delivery carriers for biomedical applications
inferredcites →https://doi.org/10.1016/j.addr.2017.05.006openalex-snapshot
Peptide ligand-modified nanomedicines for targeting cells at the tumor microenvironment
inferredcites →https://doi.org/10.1016/j.bbamcr.2014.11.006openalex-snapshot
Apoptotic human neutrophil peptide-1 anti-tumor activity revealed by cellular biomechanics
inferredcites →https://doi.org/10.1016/j.biomaterials.2011.01.067openalex-snapshot
Induction of anti-tumor cytotoxic T cell responses through PLGA-nanoparticle mediated antigen delivery
inferredcites →https://doi.org/10.1016/j.biomaterials.2017.09.017openalex-snapshot
Nanomaterials for cancer immunotherapy
inferredcites →https://doi.org/10.1016/j.biomaterials.2018.07.052openalex-snapshot
Poly(propylacrylic acid)-peptide nanoplexes as a platform for enhancing the immunogenicity of neoantigen cancer vaccines
inferredcites →https://doi.org/10.1016/j.biomaterials.2018.12.019openalex-snapshot
Poly(lactic acid) nanoparticles and cell-penetrating peptide potentiate mRNA-based vaccine expression in dendritic cells triggering their activation
inferredcites →https://doi.org/10.1016/j.ccr.2005.10.012openalex-snapshot
TGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance
inferredcites →https://doi.org/10.1016/j.ccr.2009.06.017openalex-snapshot
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
inferredcites →https://doi.org/10.1016/j.ccr.2011.02.006openalex-snapshot
CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3
inferredcites →https://doi.org/10.1016/j.coi.2013.02.009openalex-snapshot
Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment
inferredcites →https://doi.org/10.1016/j.ejca.2012.11.005openalex-snapshot
Impact of dendritic cell vaccines pulsed with Wilms’ tumour-1 peptide antigen on the survival of patients with advanced non-small cell lung cancers
inferredcites →https://doi.org/10.1016/j.ejpb.2012.11.006openalex-snapshot
Optimization of encapsulation of a synthetic long peptide in PLGA nanoparticles: Low-burst release is crucial for efficient CD8+ T cell activation
inferredcites →https://doi.org/10.1016/j.imbio.2008.11.009openalex-snapshot
Alternative activation of macrophages: Immune function and cellular biology
inferredcites →https://doi.org/10.1016/j.imlet.2013.07.003openalex-snapshot
B-cell epitope peptide vaccination targeting dimer interface of epidermal growth factor receptor (EGFR)
inferredcites →https://doi.org/10.1016/j.imlet.2014.04.010openalex-snapshot
Identification of novel helper epitope peptides of Survivin cancer-associated antigen applicable to developing helper/killer-hybrid epitope long peptide cancer vaccine
inferredcites →https://doi.org/10.1016/j.immuni.2010.05.007openalex-snapshot
Alternative Activation of Macrophages: Mechanism and Functions
inferredcites →https://doi.org/10.1016/j.intimp.2014.05.001openalex-snapshot
A novel ligand-independent peptide inhibitor of TREM-1 suppresses tumor growth in human lung cancer xenografts and prolongs survival of mice with lipopolysaccharide-induced septic shock
inferredcites →https://doi.org/10.1016/j.jconrel.2015.12.057openalex-snapshot
Synthesis and evaluation of multivalent M2pep peptides for targeting alternatively activated M2 macrophages
inferredcites →https://doi.org/10.1016/j.jconrel.2018.09.029openalex-snapshot
Peptide-decorated polymeric nanomedicines for precision cancer therapy
inferredcites →https://doi.org/10.1016/j.lungcan.2014.07.018openalex-snapshot
A phase II trial evaluating the clinical and immunologic response of HLA-A2+ non-small cell lung cancer patients vaccinated with an hTERT cryptic peptide
inferredcites →https://doi.org/10.1016/j.trecan.2016.10.010openalex-snapshot
B Lymphocytes and Cancer: A Love–Hate Relationship
inferredcites →https://doi.org/10.1016/s0065-2776(08)60911-6openalex-snapshot
Escape of Human Solid Tumors from T–Cell Recognition: Molecular Mechanisms and Functional Significance
inferredcites →https://doi.org/10.1016/s0140-6736(95)92408-6openalex-snapshot
Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation
inferredcites →https://doi.org/10.1016/s1470-2045(16)00099-1openalex-snapshot
Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial
inferredcites →https://doi.org/10.1021/acs.nanolett.8b01071openalex-snapshot
Sequentially Responsive Therapeutic Peptide Assembling Nanoparticles for Dual-Targeted Cancer Immunotherapy
inferredcites →https://doi.org/10.1021/acs.nanolett.8b01406openalex-snapshot
Engineering Dendritic-Cell-Based Vaccines and PD-1 Blockade in Self-Assembled Peptide Nanofibrous Hydrogel to Amplify Antitumor T-Cell Immunity
inferredcites →https://doi.org/10.1021/acs.nanolett.8b03096openalex-snapshot
Unique Photochemo-Immuno-Nanoplatform against Orthotopic Xenograft Oral Cancer and Metastatic Syngeneic Breast Cancer
inferredcites →https://doi.org/10.1021/acsbiomaterials.7b00561openalex-snapshot
A Supramolecular Vaccine Platform Based on α-Helical Peptide Nanofibers
inferredcites →https://doi.org/10.1021/acsnano.5b02153openalex-snapshot
Polyelectrolyte Multilayers Assembled Entirely from Immune Signals on Gold Nanoparticle Templates Promote Antigen-Specific T Cell Response
inferredcites →https://doi.org/10.1021/acsnano.7b05465openalex-snapshot
Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages
inferredcites →https://doi.org/10.1021/acsnano.8b05950openalex-snapshot
Nanoparticles for Immune Stimulation Against Infection, Cancer, and Autoimmunity
inferredcites →https://doi.org/10.1021/nn502975ropenalex-snapshot
Nanogel-Based Immunologically Stealth Vaccine Targets Macrophages in the Medulla of Lymph Node and Induces Potent Antitumor Immunity
inferredcites →https://doi.org/10.1038/354082a0openalex-snapshot
A new type of synthetic peptide library for identifying ligand-binding activity
inferredcites →https://doi.org/10.1038/nature10673openalex-snapshot
Cancer immunotherapy comes of age
inferredcites →https://doi.org/10.1038/nbt.4047openalex-snapshot
Scaffolds that mimic antigen-presenting cells enable ex vivo expansion of primary T cells
inferredcites →https://doi.org/10.1038/nbt0202-149openalex-snapshot
Enhancement of antitumor immunity by prolonging antigen presentation on dendritic cells
inferredcites →https://doi.org/10.1038/ni.3518openalex-snapshot
Targeting natural killer cells in cancer immunotherapy
inferredcites →https://doi.org/10.1038/nm0398-321openalex-snapshot
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
inferredcites →https://doi.org/10.1038/nm1100openalex-snapshot
Cancer immunotherapy: moving beyond current vaccines
inferredcites →https://doi.org/10.1038/nm720openalex-snapshot
A tumor-homing peptide with a targeting specificity related to lymphatic vessels
inferredcites →https://doi.org/10.1038/nmat4822openalex-snapshot
Designer vaccine nanodiscs for personalized cancer immunotherapy
inferredcites →https://doi.org/10.1038/nrc1929openalex-snapshot
Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors
inferredcites →https://doi.org/10.1038/nrc3239openalex-snapshot
The blockade of immune checkpoints in cancer immunotherapy
inferredcites →https://doi.org/10.1038/nrclinonc.2013.208openalex-snapshot
Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer
inferredcites →https://doi.org/10.1038/nri1785openalex-snapshot
Neutrophils and immunity: challenges and opportunities
inferredcites →https://doi.org/10.1038/nri1841openalex-snapshot
Neutrophil serine proteases: specific regulators of inflammation
inferredcites →https://doi.org/10.1038/nri3024openalex-snapshot
Neutrophils in the activation and regulation of innate and adaptive immunity
inferredcites →https://doi.org/10.1038/nri3727openalex-snapshot
Dendritic cell-targeted vaccines — hope or hype?
inferredcites →https://doi.org/10.1038/nri978openalex-snapshot
Alternative activation of macrophages
inferredcites →https://doi.org/10.1038/s41423-018-0027-xopenalex-snapshot
Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer
inferredcites →https://doi.org/10.1038/s41571-019-0222-4openalex-snapshot
Tumour-associated neutrophils in patients with cancer
inferredcites →https://doi.org/10.1038/s41590-018-0082-6openalex-snapshot
Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells
inferredcites →https://doi.org/10.1038/s41590-018-0229-5openalex-snapshot
Unique pattern of neutrophil migration and function during tumor progression
inferredcites →https://doi.org/10.1038/s41598-017-02449-xopenalex-snapshot
Peptide-specific engagement of the activating NK cell receptor KIR2DS1
inferredcites →https://doi.org/10.1038/srep36865openalex-snapshot
Cancer derived peptide of vacuolar ATPase ‘a2’ isoform promotes neutrophil migration by autocrine secretion of IL-8
inferredcites →https://doi.org/10.1039/c4cs00139gopenalex-snapshot
“Click” reactions: a versatile toolbox for the synthesis of peptide-conjugates
inferredcites →https://doi.org/10.1039/c7tb02012kopenalex-snapshot
Multi-targeting peptides for gene carriers with high transfection efficiency
inferredcites →https://doi.org/10.1056/nejmoa1012863openalex-snapshot
gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma
inferredcites →https://doi.org/10.1056/nejmoa1305133openalex-snapshot
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
inferredcites →https://doi.org/10.1056/nejmoa1414428openalex-snapshot
Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
inferredcites →https://doi.org/10.1056/nejmoa1500596openalex-snapshot
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
inferredcites →https://doi.org/10.1056/nejmoa1503093openalex-snapshot
Pembrolizumab versus Ipilimumab in Advanced Melanoma
inferredcites →https://doi.org/10.1056/nejmoa1504627openalex-snapshot
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1073/pnas.062189599openalex-snapshot
A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo
inferredcites →https://doi.org/10.1073/pnas.1304366110openalex-snapshot
Synergistic inhibition of natural killer cells by the nonsignaling molecule CD94
inferredcites →https://doi.org/10.1073/pnas.1312197110openalex-snapshot
Targeted delivery of proapoptotic peptides to tumor-associated macrophages improves survival
inferredcites →https://doi.org/10.1073/pnas.141226398openalex-snapshot
Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy
inferredcites →https://doi.org/10.1074/jbc.m116.773051openalex-snapshot
Neuropilin-1 mediates neutrophil elastase uptake and cross-presentation in breast cancer cells
inferredcites →https://doi.org/10.1080/10717544.2018.1477857openalex-snapshot
Nanoparticle drug delivery systems: an excellent carrier for tumor peptide vaccines
inferredcites →https://doi.org/10.1080/2162402x.2018.1511506openalex-snapshot
Trial watch: Peptide-based vaccines in anticancer therapy
inferredcites →https://doi.org/10.1080/21645515.2015.1026495openalex-snapshot
A paradigm shift: Cancer therapy with peptide-based B-cell epitopes and peptide immunotherapeutics targeting multiple solid tumor types: Emerging concepts and validation of combination immunotherapy
inferredcites →https://doi.org/10.1084/jem.180.1.347openalex-snapshot
Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes.
inferredcites →https://doi.org/10.1093/ilar.46.3.258openalex-snapshot
Monoclonal Versus Polyclonal Antibodies: Distinguishing Characteristics, Applications, and Information Resources
inferredcites →https://doi.org/10.1093/jnci/94.11.805openalex-snapshot
Cancer Immunotherapy With Peptide-Based Vaccines: What Have We Achieved? Where Are We Going?
inferredcites →https://doi.org/10.1093/jnci/dji373openalex-snapshot
Vaccination With Cetuximab Mimotopes and Biological Properties of Induced Anti–Epidermal Growth Factor Receptor Antibodies
inferredcites →https://doi.org/10.1097/cji.0000000000000020openalex-snapshot
Wilms Tumor Gene (WT1) Peptide–based Cancer Vaccine Combined With Gemcitabine for Patients With Advanced Pancreatic Cancer
inferredcites →https://doi.org/10.1097/cji.0b013e318133451copenalex-snapshot
Vaccination of Metastatic Colorectal Cancer Patients With Matured Dendritic Cells Loaded With Multiple Major Histocompatibility Complex Class I Peptides
inferredcites →https://doi.org/10.1111/cas.12650openalex-snapshot
Cancer immunotherapy using novel tumor‐associated antigenic peptides identified by genome‐wide cDNA microarray analyses
inferredcites →https://doi.org/10.1111/imm.12023openalex-snapshot
Anti‐tumour strategies aiming to target tumour‐associated macrophages
inferredcites →https://doi.org/10.1111/imr.12315openalex-snapshot
NK cells: tuned by peptide?
inferredcites →https://doi.org/10.1124/mol.116.108084openalex-snapshot
Tumor Microenvironment Targeting and Responsive Peptide-Based Nanoformulations for Improved Tumor Therapy
inferredcites →https://doi.org/10.1126/science.1229568openalex-snapshot
Minimal "Self" Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles
inferredcites →https://doi.org/10.1126/scitranslmed.3008211openalex-snapshot
Improved Survival with T Cell Clonotype Stability After Anti–CTLA-4 Treatment in Cancer Patients
inferredcites →https://doi.org/10.1146/annurev.immunol.021908.132532openalex-snapshot
Alternative Activation of Macrophages: An Immunologic Functional Perspective
inferredcites →https://doi.org/10.1155/2015/761820openalex-snapshot
Peptide-Based Treatment: A Promising Cancer Therapy
inferredcites →https://doi.org/10.1158/0008-5472.can-07-3243openalex-snapshot
Cancer-Testis Antigen Lymphocyte Antigen 6 Complex Locus K Is a Serologic Biomarker and a Therapeutic Target for Lung and Esophageal Carcinomas
inferredcites →https://doi.org/10.1158/0008-5472.can-10-2583openalex-snapshot
Tumor-Associated Neutrophils: New Targets for Cancer Therapy
inferredcites →https://doi.org/10.1158/1078-0432.ccr-14-3175openalex-snapshot
Cancer Neoantigens and Applications for Immunotherapy
inferredcites →https://doi.org/10.1158/2326-6066.cir-16-0283openalex-snapshot
Efficient Eradication of Established Tumors in Mice with Cationic Liposome-Based Synthetic Long-Peptide Vaccines
inferredcites →https://doi.org/10.1158/2326-6066.cir-17-0035openalex-snapshot
Peptide Blocking of PD-1/PD-L1 Interaction for Cancer Immunotherapy
inferredcites →https://doi.org/10.1159/000453569openalex-snapshot
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
inferredcites →https://doi.org/10.1159/000455014openalex-snapshot
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
inferredcites →https://doi.org/10.1172/jci11752openalex-snapshot
Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients
inferredcites →https://doi.org/10.1172/jci46102openalex-snapshot
Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients
inferredcites →https://doi.org/10.1172/jci87624openalex-snapshot
Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors
inferredcites →https://doi.org/10.1182/blood-2007-09-077438openalex-snapshot
Human natural killer cells
inferredcites →https://doi.org/10.1182/blood.v93.5.1738openalex-snapshot
Cell-Specific Peptide Binding by Human Neutrophils
inferredcites →https://doi.org/10.1183/09031936.00111908openalex-snapshot
Epithelial neutrophil-activating peptide-78 recruits neutrophils into pleural effusion
inferredcites →https://doi.org/10.1186/1471-2407-5-8openalex-snapshot
Upregulated expression of human neutrophil peptides 1, 2 and 3 (HNP 1-3) in colon cancer serum and tumours: a biomarker study
inferredcites →https://doi.org/10.1186/bcr3685openalex-snapshot
Feasibility study of personalized peptide vaccination for metastatic recurrent triple-negative breast cancer patients
inferredcites →https://doi.org/10.1200/jco.2012.43.7103openalex-snapshot
Adjuvant MAGE-A3 Immunotherapy in Resected Non–Small-Cell Lung Cancer: Phase II Randomized Study Results
inferredcites →https://doi.org/10.1371/journal.pone.0190638openalex-snapshot
EpCAM peptide-primed dendritic cell vaccination confers significant anti-tumor immunity in hepatocellular carcinoma cells
inferredcites →https://doi.org/10.1371/journal.pone.0200444openalex-snapshot
CD177-mediated nanoparticle targeting of human and mouse neutrophils
inferredcites →https://doi.org/10.1517/14712598.4.2.181openalex-snapshot
Peptide-based vaccines for cancer immunotherapy
inferredcites →https://doi.org/10.1517/14712598.6.9.905openalex-snapshot
Development of recombinant human polyclonal antibodies for the treatment of complex human diseases
inferredcites →https://doi.org/10.1517/14712598.7.5.599openalex-snapshot
Cellular liaisons of natural killer lymphocytes in immunology and immunotherapy of cancer
inferredcites →https://doi.org/10.1586/1744666x.2014.916211openalex-snapshot
Breast cancer immunotherapy: monoclonal antibodies and peptide-based vaccines
inferredcites →https://doi.org/10.1593/neo.14182openalex-snapshot
Efficacy of an EGFR-Specific Peptide against EGFR-Dependent Cancer Cell Lines and Tumor Xenografts
inferredcites →https://doi.org/10.18632/oncotarget.17845openalex-snapshot
Blockage of FOXP3 transcription factor dimerization and FOXP3/AML1 interaction inhibits T regulatory cell activity: sequence optimization of a peptide inhibitor
inferredcites →https://doi.org/10.18632/oncotarget.21157openalex-snapshot
Apolipoprotein A-I mimetic peptide 4F suppresses tumor-associated macrophages and pancreatic cancer progression
inferredcites →https://doi.org/10.18632/oncotarget.9624openalex-snapshot
A novel peptide targeting Clec9a on dendritic cell for cancer immunotherapy
inferredcites →https://doi.org/10.18632/oncotarget.9885openalex-snapshot
Targeted gene silencing of CCL2 inhibits triple negative breast cancer progression by blocking cancer stem cell renewal and M2 macrophage recruitment
inferredcites →https://doi.org/10.2147/btt.s55196openalex-snapshot
Therapeutic vaccines and cancer: focus on DPX-0907
inferredcites →https://doi.org/10.2147/nano.2006.1.1.97openalex-snapshot
Peptide crosslinked micelles: a new strategy for the design and synthesis of peptide vaccines
inferredcites →https://doi.org/10.2174/0929867321666140205132936openalex-snapshot
Personalized Peptide Vaccine for Treatment of Advanced Cancer
inferredcites →https://doi.org/10.2174/0929867321666140217122100openalex-snapshot
Tumor Homing Peptides as Molecular Probes for Cancer Therapeutics, Diagnostics and Theranostics
inferredcites →https://doi.org/10.3389/fimmu.2014.00133openalex-snapshot
Effects of Peptide on NK Cell-Mediated MHC I Recognition
inferredcites →https://doi.org/10.3389/fimmu.2018.00884openalex-snapshot
Approaches to Improve Chemically Defined Synthetic Peptide Vaccines
inferredcites →https://doi.org/10.3389/fmed.2017.00018openalex-snapshot
MAGE-A Antigens and Cancer Immunotherapy
inferredcites →https://doi.org/10.3390/pharmaceutics10040263openalex-snapshot
A Comprehensive Map of FDA-Approved Pharmaceutical Products
inferredcites →https://doi.org/10.3892/ijo.24.4.909openalex-snapshot
Dendritic cell-based immunotherapy of cancer with carcinoembryonic antigen-derived, HLA-A24-restricted CTL epitope: Clinical outcomes of 18 patients with metastatic gastrointestinal or lung adenocarcinomas
inferredcites →https://doi.org/10.4049/jimmunol.160.4.1750openalex-snapshot
Enhanced Generation of Specific Tumor-Reactive CTL In Vitro by Selected Melan-A/MART-1 Immunodominant Peptide Analogues
inferredcites →https://doi.org/10.4049/jimmunol.179.8.5033openalex-snapshot
CD8+ CTL Priming by Exact Peptide Epitopes in Incomplete Freund’s Adjuvant Induces a Vanishing CTL Response, whereas Long Peptides Induce Sustained CTL Reactivity
inferredcites →https://doi.org/10.4161/hv.29275openalex-snapshot
Depletion of tumor-associated macrophages enhances the anti-tumor immunity induced by a Toll-like receptor agonist-conjugated peptide
inferredcites →https://doi.org/10.7150/thno.20745openalex-snapshot
Rational design of Polymeric Hybrid Micelles to Overcome Lymphatic and Intracellular Delivery Barriers in Cancer Immunotherapy
inferredcites →https://doi.org/10.7150/thno.24110openalex-snapshot
Platinum-Based Nanovectors Engineered with Immuno-Modulating Adjuvant for Inhibiting Tumor growth and Promoting Immunity
inferredcites →https://doi.org/10.7150/thno.24387openalex-snapshot
Personalized cancer neoantigen vaccines come of age
inferredcites →https://doi.org/10.7150/thno.29431openalex-snapshot
Engineering Nanoparticles for Targeted Remodeling of the Tumor Microenvironment to Improve Cancer Immunotherapy
inferredcites →https://doi.org/10.7150/thno.30577openalex-snapshot
Injectable polypeptide hydrogel-based co-delivery of vaccine and immune checkpoint inhibitors improves tumor immunotherapy
inferredcites →https://doi.org/10.7150/thno.34031openalex-snapshot
A versatile supramolecular nanoadjuvant that activates NF-κB for cancer immunotherapy

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4848374openalex-extracted
Peptide-Functionalized Magnetic Micro/Nanocapsules Loaded with Dexamethasone for Dual Active Targeted Treatment of Inner Ear Inflammation
inferred← citeshttps://doi.org/10.1002/9783527841264.ch22openalex-snapshot
Self‐assembling Bioactive Peptides for Supramolecular Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/adfm.202521597openalex-snapshot
Self‐Assembling Peptide‐Based Materials for Therapy of Inflammatory Diseases
inferred← citeshttps://doi.org/10.1002/adhm.202400512openalex-snapshot
Immunomodulatory Peptides for Tumor Treatment
inferred← citeshttps://doi.org/10.1002/adhm.202500551openalex-snapshot
Dendrimer Conjugates with PD‐L1‐Binding Peptides Enhance In Vivo Antitumor Immune Response
inferred← citeshttps://doi.org/10.1002/adma.202306736openalex-snapshot
A Transformable Supramolecular Bispecific Cell Engager for Augmenting Natural Killer and T Cell‐Based Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/advs.202305998openalex-snapshot
Crosstalk Between NK Cell Receptors and Tumor Membrane Hsp70‐Derived Peptide: A Combined Computational and Experimental Study
inferred← citeshttps://doi.org/10.1002/asia.202100901openalex-snapshot
In Vitro Anticancer Activity of Nanoformulated Mono‐ and Di‐nuclear Pt Compounds
inferred← citeshttps://doi.org/10.1002/celc.202300301openalex-snapshot
Ferrocene‐Peptide Conjugate for the Detection and Quantification of Ascorbic Acid
inferred← citeshttps://doi.org/10.1002/exp.20210146openalex-snapshot
From structural design to delivery: mRNA therapeutics for cancer immunotherapy
inferred← citeshttps://doi.org/10.1002/ijc.33971openalex-snapshot
On the development of a neoantigen vaccine for the prevention of Lynch Syndrome
inferred← citeshttps://doi.org/10.1002/psc.3664openalex-snapshot
The Potential Effect of Endogenous Antimicrobial Peptides in Cancer Immunotherapy and Prevention
inferred← citeshttps://doi.org/10.1002/slct.202302947openalex-snapshot
Lipoic Acid Ligase A‐Mediated Ligation: Mechanism, Applications, and Emerging Innovations in Bioconjugation
inferred← citeshttps://doi.org/10.1002/smll.202205787openalex-snapshot
Self‐Assembled Peptide‐Based Nanodrugs: Molecular Design, Synthesis, Functionalization, and Targeted Tumor Bioimaging and Biotherapy
inferred← citeshttps://doi.org/10.1002/smtd.202201518openalex-snapshot
DNA Nanomaterials‐Based Platforms for Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/sstr.202000068openalex-snapshot
Supramolecular Immunotherapy of Cancer Based on the Self‐Assembling Peptide Design
inferred← citeshttps://doi.org/10.1002/wnan.70005openalex-snapshot
Biomimetic Nanomaterials Based on Peptide In Situ Self‐Assembly for Immunotherapy Applications
inferred← citeshttps://doi.org/10.1007/16833_2024_258openalex-snapshot
Immune Checkpoint Inhibitors: Novel Therapies and Targets
inferred← citeshttps://doi.org/10.1007/978-1-0716-1884-4_35openalex-snapshot
Beyond Sequencing: Prioritizing and Delivering Neoantigens for Cancer Vaccines
inferred← citeshttps://doi.org/10.1007/978-981-16-9535-3_17openalex-snapshot
Immunoimaging
inferred← citeshttps://doi.org/10.1007/978-981-96-8646-9_8openalex-snapshot
Bio-sensing Materials
inferred← citeshttps://doi.org/10.1007/978-981-99-1718-1_4openalex-snapshot
Recent Progress in Hypoxia-Targeting: Peptide-Based Nanomaterials
inferred← citeshttps://doi.org/10.1007/s10856-021-06526-6openalex-snapshot
In vitro assessment of antitumor immune responses using tumor antigen proteins produced by transgenic silkworms
inferred← citeshttps://doi.org/10.1007/s10930-025-10290-9openalex-snapshot
Design and Verification Process of a Structure-Altering Peptide as a Microtubule Allosteric Polypeptide Against Cancer
inferred← citeshttps://doi.org/10.1007/s10989-021-10270-4openalex-snapshot
The Role of Peptide-Based Tumor Vaccines on Cytokines of Adaptive Immunity: A Review
inferred← citeshttps://doi.org/10.1007/s10989-021-10289-7openalex-snapshot
Role of Different Peptides for Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1007/s12013-025-01830-2openalex-snapshot
In Silico Development of a Multi-epitope Vaccine Targeting TFDP3: A Novel Approach for Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1007/s12192-021-01229-xopenalex-snapshot
HSP70iQ435A to subdue autoimmunity and support anti-tumor responses
inferred← citeshttps://doi.org/10.1007/s13233-021-9011-xopenalex-snapshot
Peptide Materials for Smart Therapeutic Applications
inferred← citeshttps://doi.org/10.1016/b978-0-12-823686-4.00019-7openalex-snapshot
Cancer immunotherapy
inferred← citeshttps://doi.org/10.1016/b978-0-323-85661-4.00016-0openalex-snapshot
Advanced biomaterials and scaffolds for cancer immunotherapy
inferred← citeshttps://doi.org/10.1016/b978-0-323-91146-7.00003-2openalex-snapshot
Approaches to cancer vaccination
inferred← citeshttps://doi.org/10.1016/b978-0-323-91248-8.00013-1openalex-snapshot
Stimuli-responsive protein fibers for advanced applications
inferred← citeshttps://doi.org/10.1016/b978-0-323-91924-1.00009-5openalex-snapshot
Vaccines and sera
inferred← citeshttps://doi.org/10.1016/b978-0-443-22374-7.00022-0openalex-snapshot
Lipid-based peptide and gene delivery to lungs
inferred← citeshttps://doi.org/10.1016/b978-0-443-27745-0.00013-2openalex-snapshot
Applications of self-assembled peptide nanofibers in cancer immunotherapy
inferred← citeshttps://doi.org/10.1016/j.addr.2020.05.005openalex-snapshot
Membrane-core nanoparticles for cancer nanomedicine
inferred← citeshttps://doi.org/10.1016/j.addr.2022.114446openalex-snapshot
Imaging-guided/improved diseases management for immune-strategies and beyond
inferred← citeshttps://doi.org/10.1016/j.apmt.2021.101063openalex-snapshot
Peptide-based assemblies as immune checkpoint inhibitor delivery systems for enhanced immunotherapy
inferred← citeshttps://doi.org/10.1016/j.apsb.2024.05.013openalex-snapshot
Insights into therapeutic peptides in the cancer-immunity cycle: Update and challenges
inferred← citeshttps://doi.org/10.1016/j.bbcan.2024.189197openalex-snapshot
Advancements in therapeutic peptides: Shaping the future of cancer treatment
inferred← citeshttps://doi.org/10.1016/j.bcp.2026.117724openalex-snapshot
Unraveling the glioblastoma (GBM) tumor microenvironment: future perspective on targeted immunotherapy
inferred← citeshttps://doi.org/10.1016/j.biosystems.2024.105177openalex-snapshot
An integrative machine learning model for the identification of tumor T-cell antigens
inferred← citeshttps://doi.org/10.1016/j.canlet.2026.218736openalex-snapshot
Multifunctional nano-vaccines integrating lipid-conjugated tumor antigens with TLR/STING agonists enhance cancer immunotherapy
inferred← citeshttps://doi.org/10.1016/j.ccr.2023.215374openalex-snapshot
Recent advance in tailoring the structure and functions of self-assembled peptide nanomaterials for biomedical applications
inferred← citeshttps://doi.org/10.1016/j.compbiolchem.2025.108440openalex-snapshot
A comprehensive review and evaluation of machine learning-based approaches for identifying tumor T cell antigens
inferred← citeshttps://doi.org/10.1016/j.compbiomed.2022.106368openalex-snapshot
PSRTTCA: A new approach for improving the prediction and characterization of tumor T cell antigens using propensity score representation learning
inferred← citeshttps://doi.org/10.1016/j.compbiomed.2023.106929openalex-snapshot
TNFepitope: A webserver for the prediction of TNF-α inducing epitopes
inferred← citeshttps://doi.org/10.1016/j.csbj.2025.10.035openalex-snapshot
PredLyP: A computational tool for predicting tissue-specific (phago-)lysosomal post-digestion peptides
inferred← citeshttps://doi.org/10.1016/j.drudis.2024.103981openalex-snapshot
Peptide-functionalized, -assembled and -loaded nanoparticles in cancer therapy
inferred← citeshttps://doi.org/10.1016/j.ejphar.2021.174512openalex-snapshot
Strategies for active tumor targeting-an update
inferred← citeshttps://doi.org/10.1016/j.esmoop.2021.100278openalex-snapshot
Emerging targets for anticancer vaccination: PD-1
inferred← citeshttps://doi.org/10.1016/j.insi.2026.100196openalex-snapshot
Animal-sourced probiotic bacteria induce interferon gamma in humans and mice
inferred← citeshttps://doi.org/10.1016/j.jconrel.2022.10.004openalex-snapshot
Nanomedicine for advanced cancer immunotherapy
inferred← citeshttps://doi.org/10.1016/j.jiec.2020.11.015openalex-snapshot
Immunotherapeutic strategies for the treatment of ovarian cancer: current status and future direction
inferred← citeshttps://doi.org/10.1016/j.jpet.2026.104324openalex-snapshot
Peptide-mediated immunomodulation of tumor microenvironment in triple-negative breast cancer: A comprehensive review
inferred← citeshttps://doi.org/10.1016/j.pdpdt.2022.103174openalex-snapshot
Immunogenic analysis of epitope-based vaccine candidate induced by photodynamic therapy in MDA-MB-231 triple-negative breast cancer cells
inferred← citeshttps://doi.org/10.1016/j.polymer.2024.127864openalex-snapshot
Peptide-functionalized magnetic microcapsules loaded with dexamethasone for dual active targeted treatment of inner ear inflammation
inferred← citeshttps://doi.org/10.1016/j.prp.2023.154735openalex-snapshot
Breast cancer vaccines; A comprehensive and updated review
inferred← citeshttps://doi.org/10.1016/j.redox.2020.101846openalex-snapshot
Targeting mitochondrial ion channels for cancer therapy
inferred← citeshttps://doi.org/10.1021/acs.biochem.5c00826openalex-snapshot
Advanced Peptide Modifications for Superior Therapeutics
inferred← citeshttps://doi.org/10.1021/acs.bioconjchem.1c00437openalex-snapshot
Enhancing Cancer Immunotherapeutic Efficacy with Sonotheranostic Strategies
inferred← citeshttps://doi.org/10.1021/acsabm.5c01243openalex-snapshot
Self-Assembled Peptide Nanoparticle-Mediated Macrophage Polarization Enhances Anticancer Efficacy of Chemotherapeutics in Triple-Negative Breast Cancer
inferred← citeshttps://doi.org/10.1021/acsabm.6c01021openalex-snapshot
Self-Assembling Amphiphilic Cationic Peptide-Based Nanoarchitectures for Soft Biomaterials with Potential Antimicrobial Activity against Clinically Isolated Multidrug-Resistant Bacteria
inferred← citeshttps://doi.org/10.1021/acsami.5c03021openalex-snapshot
Highly Efficient Bifunctional Peptides for Tumor Immunotherapy by Simultaneously Activating T Cells and Blocking PD-L1 Immune Checkpoint
inferred← citeshttps://doi.org/10.1021/acsnano.4c01518openalex-snapshot
Metal–Organic Framework-Based Nanovaccine for Relieving Immunosuppressive Tumors via Hindering Efferocytosis of Macrophages and Promoting Pyroptosis and Cuproptosis of Cancer Cells
inferred← citeshttps://doi.org/10.1021/acsnanomed.6c00046openalex-snapshot
Multivalent Peptide Nanotherapeutics Enhance Epidermal Growth Factor Receptor Binding, Modulate Associated Signaling, and Suppress Tumor Growth
inferred← citeshttps://doi.org/10.1021/acsomega.2c03974openalex-snapshot
Functionalized Peptide-Based Nanoparticles for Targeted Cancer Nanotherapeutics: A State-of-the-Art Review
inferred← citeshttps://doi.org/10.1038/s41423-024-01226-xopenalex-snapshot
Immunotherapy for glioblastoma: current state, challenges, and future perspectives
inferred← citeshttps://doi.org/10.1038/s41541-022-00483-zopenalex-snapshot
Chimeric adenoviral (Ad5.F35) and listeria vector prime-boost immunization is safe and effective for cancer immunotherapy
inferred← citeshttps://doi.org/10.1038/s41551-020-0599-5openalex-snapshot
Burst release of encapsulated annexin A5 in tumours boosts cytotoxic T-cell responses by blocking the phagocytosis of apoptotic cells
inferred← citeshttps://doi.org/10.1038/s41598-024-77957-8openalex-snapshot
A hybrid method for discovering interferon-gamma inducing peptides in human and mouse
inferred← citeshttps://doi.org/10.1039/d1cc06355copenalex-snapshot
Supramolecular cancer photoimmunotherapy based on precise peptide self-assembly design
inferred← citeshttps://doi.org/10.1039/d1na00637aopenalex-snapshot
Recent advances in peptide-based nanomaterials for targeting hypoxia
inferred← citeshttps://doi.org/10.1039/d4tb00674gopenalex-snapshot
Peptide nanovaccine conjugated via a retro-Diels–Alder reaction linker for overcoming the obstacle in lymph node penetration and eliciting robust cellular immunity
inferred← citeshttps://doi.org/10.1039/d5mh01621eopenalex-snapshot
Fluorobenzylation promotes immune-activating peptides to turn cold tumors into hot tumors
inferred← citeshttps://doi.org/10.1080/07391102.2021.1883111openalex-snapshot
Exploring the cancer-testis antigen BORIS to design a novel multi-epitope vaccine against breast cancer based on immunoinformatics approaches
inferred← citeshttps://doi.org/10.1080/10717544.2022.2058647openalex-snapshot
Self-assembling peptides-based nano-cargos for targeted chemotherapy and immunotherapy of tumors: recent developments, challenges, and future perspectives
inferred← citeshttps://doi.org/10.1080/14728214.2023.2218643openalex-snapshot
Emerging peptide therapeutics for the treatment of ovarian cancer
inferred← citeshttps://doi.org/10.1080/17425247.2022.2045943openalex-snapshot
Recent advances in targeted drug delivery for the treatment of pancreatic ductal adenocarcinoma
inferred← citeshttps://doi.org/10.1080/17435889.2026.2623935openalex-snapshot
Applications of engineered peptide nanomaterials in enhanced cancer imaging
inferred← citeshttps://doi.org/10.1111/cas.14765openalex-snapshot
First‐in‐human study of the cancer peptide vaccine TAS0313 in patients with advanced solid tumors
inferred← citeshttps://doi.org/10.1111/cbdd.14180openalex-snapshot
Peptide‐based diagnostic and therapeutic agents: Where we are and where we are heading?
inferred← citeshttps://doi.org/10.1136/jitc-2025-011479openalex-snapshot
O -GlcNAc transferase promotes immune evasion and immunotherapy resistance in uterine corpus endometrial cancer by targeting the glucocorticoid receptor
inferred← citeshttps://doi.org/10.1158/1535-7163.22522525openalex-snapshot
Supplementary Figure from Peptide PDHPS1 Inhibits Ovarian Cancer Growth through Disrupting YAP Signaling
inferred← citeshttps://doi.org/10.1158/1535-7163.c.6543412.v1openalex-snapshot
Data from Peptide PDHPS1 Inhibits Ovarian Cancer Growth through Disrupting YAP Signaling
inferred← citeshttps://doi.org/10.1158/1535-7163.mct-21-0848openalex-snapshot
Peptide PDHPS1 Inhibits Ovarian Cancer Growth through Disrupting YAP Signaling
inferred← citeshttps://doi.org/10.1186/s12859-023-05421-xopenalex-snapshot
StackTTCA: a stacking ensemble learning-based framework for accurate and high-throughput identification of tumor T cell antigens
inferred← citeshttps://doi.org/10.1186/s12935-021-02223-0openalex-snapshot
Licorice extract inhibits growth of non-small cell lung cancer by down-regulating CDK4-Cyclin D1 complex and increasing CD8+ T cell infiltration
inferred← citeshttps://doi.org/10.1186/s12951-021-00999-xopenalex-snapshot
Supramolecular peptide nano-assemblies for cancer diagnosis and therapy: from molecular design to material synthesis and function-specific applications
inferred← citeshttps://doi.org/10.1515/9783111593654-007openalex-snapshot
171Chapter 6 Precision oncology: nanoemulsions as pioneers in the delivery of anticancer agents, immunomodulators, and vaccines
inferred← citeshttps://doi.org/10.1590/s1677-5538.ibju.2020.0681openalex-snapshot
The role of immunotherapy in advanced renal cell carcinoma
inferred← citeshttps://doi.org/10.18632/oncotarget.27417openalex-snapshot
Toxoplasma gondii GRA8-derived peptide immunotherapy improves tumor targeting of colorectal cancer
inferred← citeshttps://doi.org/10.21203/rs.3.rs-108084/v1openalex-snapshot
A Novel Self-Assembled Epitope Peptide Nanoemulsion Vaccine with Targeting the Nasal Mucosal Epithelial Cell for Reinvigorating CD8+ T cell Immune Activity and Inhibiting Tumor Progression
inferred← citeshttps://doi.org/10.21203/rs.3.rs-2043402/v1openalex-snapshot
Efficient anti-tumor immunotherapy using tumor epitope-coated biodegradable nanoparticles combined with polyinosinic-polycytidylic acid and an anti-PD1 monoclonal antibody
inferred← citeshttps://doi.org/10.2147/ijn.s443692openalex-snapshot
Nano-Drug Delivery Systems Based on Natural Products
inferred← citeshttps://doi.org/10.2174/1381612829666230213152259openalex-snapshot
Peptide-based Self-assembly: Design, Bioactive Properties, and Its Applications
inferred← citeshttps://doi.org/10.2174/1574892817666220414110335openalex-snapshot
Altering Landscape of Cancer Vaccines: Unique Platforms, Research on Therapeutic Applications and Recent Patents
inferred← citeshttps://doi.org/10.2217/fon-2020-0224openalex-snapshot
B-Cell Epitope Peptide Cancer Vaccines: A New Paradigm for Combination Immunotherapies with Novel Checkpoint Peptide Vaccine
inferred← citeshttps://doi.org/10.22270/jddt.v15i6.7194openalex-snapshot
Drugs Based on Bioactive Oligopeptides
inferred← citeshttps://doi.org/10.3389/fchem.2022.1107600openalex-snapshot
From design to clinic: Engineered peptide nanomaterials for cancer immunotherapy
inferred← citeshttps://doi.org/10.3389/fimmu.2022.826164openalex-snapshot
Peptides-Coated Oncolytic Vaccines for Cancer Personalized Medicine
inferred← citeshttps://doi.org/10.3389/fimmu.2022.931612openalex-snapshot
Potential association factors for developing effective peptide-based cancer vaccines
inferred← citeshttps://doi.org/10.3389/fimmu.2022.983000openalex-snapshot
mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model
inferred← citeshttps://doi.org/10.3389/fonc.2023.1088038openalex-snapshot
Cancel cancer: The immunotherapeutic potential of CD200/CD200R blockade
inferred← citeshttps://doi.org/10.3390/antibiotics11111482openalex-snapshot
Study on Optimizing Novel Antimicrobial Peptides with Bifunctional Activity to Prevent and Treat Peri-Implant Disease
inferred← citeshttps://doi.org/10.3390/biom15121751openalex-snapshot
A Scorpion Peptide Exerts Selective Anti-Leukemia Effects Through Disrupting Cell Membranes and Triggering Bax/Bcl-2-Related Apoptosis Pathway
inferred← citeshttps://doi.org/10.3390/biomedicines12010202openalex-snapshot
Role of Functionalized Peptides in Nanomedicine for Effective Cancer Therapy
inferred← citeshttps://doi.org/10.3390/biomedicines13081963openalex-snapshot
Glioblastoma: From Pathophysiology to Novel Therapeutic Approaches
inferred← citeshttps://doi.org/10.3390/cancers12041049openalex-snapshot
Nanoparticles to Improve the Efficacy of Peptide-Based Cancer Vaccines
inferred← citeshttps://doi.org/10.3390/cancers14153596openalex-snapshot
FXYD3 Expression Predicts Poor Prognosis in Renal Cell Carcinoma with Immunosuppressive Tumor Microenvironment
inferred← citeshttps://doi.org/10.3390/cancers14225678openalex-snapshot
Combined Vaccination with B Cell Peptides Targeting Her-2/neu and Immune Checkpoints as Emerging Treatment Option in Cancer
inferred← citeshttps://doi.org/10.3390/cancers16040747openalex-snapshot
Characterizing the Inflammatory Profile of Neutrophil-Rich Triple-Negative Breast Cancer
inferred← citeshttps://doi.org/10.3390/cells13050413openalex-snapshot
The Use of Immune Regulation in Treating Head and Neck Squamous Cell Carcinoma (HNSCC)
inferred← citeshttps://doi.org/10.3390/ijms24010456openalex-snapshot
Peptide-Based Materials That Exploit Metal Coordination
inferred← citeshttps://doi.org/10.3390/molecules31172953openalex-snapshot
pH-Dependent Surface Charge Modulation of Peptide-Coated Poly(lactic-co-glycolic Acid) (PLGA) Nanoparticle for Drug Delivery in Ovarian Cancer
inferred← citeshttps://doi.org/10.3390/ph16070923openalex-snapshot
Peptide-Based Vaccine against Breast Cancer: Recent Advances and Prospects
inferred← citeshttps://doi.org/10.3390/pharmaceutics17010046openalex-snapshot
Peptides as Versatile Regulators in Cancer Immunotherapy: Recent Advances, Challenges, and Future Prospects
inferred← citeshttps://doi.org/10.3390/vaccines12070795openalex-snapshot
SARS-CoV-2 Vaccines: The Advantage of Mucosal Vaccine Delivery and Local Immunity
inferred← citeshttps://doi.org/10.4110/in.2022.22.e42openalex-snapshot
Efficient Anti-Tumor Immunotherapy Using Tumor Epitope-Coated Biodegradable Nanoparticles Combined With Polyinosinic-Polycytidylic Acid and an Anti-PD1 Monoclonal Antibody
inferred← citeshttps://doi.org/10.6084/m9.figshare.16800398openalex-snapshot
Additional file 1 of Licorice extract inhibits growth of non-small cell lung cancer by down-regulating CDK4-Cyclin D1 complex and increasing CD8+ T cell infiltration
inferred← citeshttps://doi.org/10.6084/m9.figshare.26607256openalex-snapshot
Additional file 1 of StackTTCA: a stacking ensemble learning-based framework for accurate and high-throughput identification of tumor T cell antigens
inferred← citeshttps://doi.org/10.7150/thno.45843openalex-snapshot
JP1 suppresses proliferation and metastasis of melanoma through MEK1/2 mediated NEDD4L-SP1-Integrin αvβ3 signaling
inferred← citeshttps://doi.org/10.7150/thno.48966openalex-snapshot
Critical reviews of immunotheranostics
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.